An injectable, self-assembled multicellular microsphere with the incorporation of fibroblast-derived extracellular matrix for therapeutic angiogenesis

Authors
Du, PingDa Costa, Avelino Dos SantosSavitri, CinintaHa, Sang SuWang, Peng-YuanPark, Kwideok
Issue Date
2020-08
Publisher
Elsevier BV
Citation
Materials Science and Engineering: C, v.113
Abstract
Decellularized human lung fibroblast-derived matrix (hFDM) has demonstrated its excellent proangiogenic capability. In this study, we propose a self-assembled, injectable multicellular microspheres containing human umbilical vein endothelial cells (HUVECs) and mesenchymal stem cell (MSCs), collagen hydrogel (Col), and hFDM toward therapeutic angiogenesis. Those multicellular microspheres are spontaneously formed by the mixtures of cell and hydrogel after being dropped on the parafilm for several hours. The size of microspheres can be manipulated via adjusting the initial volume of droplets and the culture period. The cells in the microspheres are highly viable. Multicellular microspheres show good capability of cell migration on 2D culture plate and also exhibit active cell sprouting in 3D environment (Col) forming capillary-like structures. We also find that multiple angiogenic-related factors are significantly upregulated with the multicellular microspheres prepared via Col and hFDM (Col/hFDM) than those prepared using Col alone or single cells (harvested from cocultured HUVECs/MSCs in monolayer). For therapeutic efficacy evaluation, three different groups of single cells, Col and Col/hFDM microspheres are injected to a hindlimb ischemic model, respectively, along with PBS injection as a control group. It is notable that Col/hFDM microspheres significantly improve the blood reperfusion and greatly attenuate the fibrosis level of the ischemic regions. In addition, Col/hFDM microspheres show higher cell engraftment level than that of the other groups. The incorporation of transplanted cells with host vasculature is detectable only with the treatment of Col/hFDM. Current results suggest that hFDM plays an important role in the multicellular microspheres for angiogenic cellular functions in vitro as well as in vivo. Taken together, our injectable multicellular microspheres (Col/hFDM) offer a very promising platform for cell delivery and tissue regenerative applications.
Keywords
MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; PROMOTES ANGIOGENESIS; LIMB ISCHEMIA; TRANSPLANTATION; QUANTIFICATION; MORPHOGENESIS; CONTRACTION; MECHANISMS; THERAPIES; MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; PROMOTES ANGIOGENESIS; LIMB ISCHEMIA; TRANSPLANTATION; QUANTIFICATION; MORPHOGENESIS; CONTRACTION; MECHANISMS; THERAPIES; Human fibroblast-derived extracellular matrix (hFDM); Human umbilical vein endothelial cells; Mesenchymal stem cells; Multicellular microsphere; Therapeutic angiogenesis; Hindlimb ischemia
ISSN
0928-4931
URI
https://pubs.kist.re.kr/handle/201004/118291
DOI
10.1016/j.msec.2020.110961
Appears in Collections:
KIST Article > 2020
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE